S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
S&P 500   3,971.27 (-0.16%)
DOW   32,394.25 (-0.12%)
QQQ   307.12 (-0.53%)
AAPL   157.65 (-0.40%)
MSFT   275.23 (-0.42%)
META   200.68 (-1.06%)
GOOGL   101.03 (-1.40%)
AMZN   97.24 (-0.82%)
TSLA   189.19 (-1.37%)
NVDA   264.10 (-0.46%)
NIO   9.20 (+3.02%)
BABA   98.40 (+14.26%)
AMD   94.56 (-2.12%)
T   18.72 (-0.79%)
F   11.60 (+0.69%)
MU   59.28 (-0.85%)
CGC   1.81 (-3.72%)
GE   93.14 (-0.18%)
DIS   94.82 (-0.84%)
AMC   5.15 (+13.19%)
PYPL   72.70 (-0.82%)
PFE   39.99 (-0.57%)
NFLX   323.52 (-1.26%)
TSE:TH

Theratechnologies - TH Stock Forecast, Price & News

C$1.07
-0.06 (-5.31%)
(As of 03/28/2023 03:59 PM ET)
Add
Compare
Today's Range
C$1.07
▼
C$1.13
50-Day Range
C$1.00
▼
C$1.40
52-Week Range
C$1.00
▼
C$3.75
Volume
16,808 shs
Average Volume
24,860 shs
Market Capitalization
C$103.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$3.25

TH stock logo

About Theratechnologies (TSE:TH) Stock

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH1902, which is in Phase 1/Part A clinical trials for the treatment of triple negative breast cancer; and TH1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Receive TH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter.

TH Stock News Headlines

March 14, 2023 | finance.yahoo.com
Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model
March 2, 2023 | finance.yahoo.com
Theratechnologies Full Year 2022 Earnings: EPS Misses Expectations
March 28, 2023 | Stansberry Research (Ad)
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
February 28, 2023 | finance.yahoo.com
Theratechnologies Reports Financial Results and Business Updates for the Fourth Quarter and Full Year Fiscal 2022
February 22, 2023 | finance.yahoo.com
Theratechnologies Presents New Tesamorelin Data Demonstrating Improvement of Metabolic Syndrome in People with HIV
February 18, 2023 | ca.finance.yahoo.com
Stocks in play: Theratechnologies Inc.
February 16, 2023 | finance.yahoo.com
Theratechnologies Announces Path to Resume TH1902 Clinical Development
February 14, 2023 | finance.yahoo.com
Theratechnologies to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update
March 28, 2023 | Stansberry Research (Ad)
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
February 10, 2023 | finance.yahoo.com
Theratechnologies Inc. (THTX) Stock Historical Prices & Data - Yahoo Finance
February 9, 2023 | markets.businessinsider.com
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED) and Mainz Biomed B.V. (MYNZ)
February 8, 2023 | theglobeandmail.com
Theratechnologies: Top 10 Undervalued Healthcare Sector Stocks on TSX (TH)
January 23, 2023 | marketwatch.com
HIV Market 2023 : Advance Technology, Latest Trend and Future Expansion by 2028
January 10, 2023 | marketwatch.com
Global HIV Antiretroviral Drug Market 2023 Size and Growth Analysis by Manufacture, Type, Application, Market Dynamic and Forecast to 2028
January 4, 2023 | finance.yahoo.com
Open Letter to Shareholders from CEO Paul Levesque
December 23, 2022 | finance.yahoo.com
Shareholders in Theratechnologies (TSE:TH) are in the red if they invested five years ago
December 1, 2022 | finance.yahoo.com
Theratechnologies Announces Update from Ongoing TH1902 Study
October 26, 2022 | finance.yahoo.com
Theratechnologies Reports Data Showing High Expression of Sortilin (SORT1) in Multiple Solid Tumors from Tissue Microarrays
October 13, 2022 | streetinsider.com
Form 6-K Theratechnologies Inc. For: Oct 13 - StreetInsider.com
October 13, 2022 | investing.com
Theratechnologies Inc. Tops Q3 EPS by 4c By Investing.com - Investing.com
October 13, 2022 | benzinga.com
Theratechnologies: Q3 Earnings Insights - Theratechnologies (NASDAQ:THTX) - Benzinga
October 13, 2022 | globenewswire.com
Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Update - GlobeNewswire
October 13, 2022 | finance.yahoo.com
Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Update
October 12, 2022 | benzinga.com
Earnings Preview: Theratechnologies - Theratechnologies (NASDAQ:THTX) - Benzinga
October 12, 2022 | globenewswire.com
Theratechnologies Presents Data Demonstrating High Expression of Sortilin (SORT1) in Multiple Tumor Types at 34th EORTC-NCI-AACR Symposium - GlobeNewswire
October 12, 2022 | finance.yahoo.com
Theratechnologies Presents Data Demonstrating High Expression of Sortilin (SORT1) in Multiple Tumor Types at 34th EORTC-NCI-AACR Symposium
October 4, 2022 | nasdaq.com
Pre-market Movers: FNGR, AERC, FAZE, ARC, ADEA… - Nasdaq
See More Headlines
Receive TH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter.

TH Company Calendar

Today
3/28/2023
Next Earnings (Estimated)
4/12/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
TSE:TH
CUSIP
N/A
CIK
N/A
Web
www.theratech.com
Phone
+1-514-3367800
Fax
N/A
Employees
87
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$3.25
High Stock Price Forecast
C$3.25
Low Stock Price Forecast
C$3.25
Forecasted Upside/Downside
+203.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

EPS (Most Recent Fiscal Year)
C($0.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
50.53
P/E Growth
-8.5
Net Income
C$-47,240,000.00
Net Margins
-59.00%
Pretax Margin
N/A
Return on Equity
-1,116.86%
Return on Assets
-19.74%

Debt

Debt-to-Equity Ratio
562.07
Current Ratio
0.64
Quick Ratio
0.64

Sales & Book Value

Annual Sales
C$80.06 million
Price / Sales
1.29
Cash Flow
C$0.28 per share
Price / Cash Flow
3.76
Book Value
C($0.23) per share
Price / Book
-4.65

Miscellaneous

Outstanding Shares
96,810,000
Free Float
N/A
Market Cap
C$103.59 million
Optionable
Not Optionable
Beta
1.58

Key Executives

  • Mr. Paul Lévesque (Age 59)
    Pres, CEO & Director
    Comp: $1.24M
  • Mr. Philippe Dubuc M.B.A. (Age 56)
    MBA, Sr. VP & CFO
    Comp: $393.59k
  • Dr. Christian Marsolais Ph.D. (Age 60)
    Sr. VP & Chief Medical Officer
    Comp: $383.71k
  • Mr. John Leasure (Age 58)
    Global Commercial Officer
    Comp: $353.81k
  • Ms. Elif McDonald
    Sr. Director of Investor Relations
  • Mr. Jocelyn Lafond L.L.M. (Age 55)
    LL.B., Gen. Counsel & Corp. Sec.
  • Mr. Denis Boucher B.A. (Age 57)
    L.L.B., VP of Communications & Corp. Affairs
  • Hon. Andre Dupras M.Sc. (Age 59)
    VP of HR

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













TH Stock - Frequently Asked Questions

Should I buy or sell Theratechnologies stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TH shares.
View TH analyst ratings or view top-rated stocks.

What is Theratechnologies' stock price forecast for 2023?

3 Wall Street research analysts have issued 12-month price objectives for Theratechnologies' stock. Their TH share price forecasts range from C$3.25 to C$3.25. On average, they predict the company's share price to reach C$3.25 in the next twelve months. This suggests a possible upside of 203.7% from the stock's current price.
View analysts price targets for TH or view top-rated stocks among Wall Street analysts.

How have TH shares performed in 2023?

Theratechnologies' stock was trading at C$1.20 at the beginning of 2023. Since then, TH stock has decreased by 10.8% and is now trading at C$1.07.
View the best growth stocks for 2023 here.

When is Theratechnologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 12th 2023.
View our TH earnings forecast.

What other stocks do shareholders of Theratechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Theratechnologies investors own include Stars Group (TSGI), Theratechnologies (THERF), BCE (BCE), ProMetic Life Sciences (PLI), Teranga Gold (TGZ), Endeavour Mining (EDV), Nemaska Lithium (NMX), Shopify (SHOP), United Therapeutics (UTHR) and Avigilon (AVO).

What is Theratechnologies' stock symbol?

Theratechnologies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TH."

How do I buy shares of Theratechnologies?

Shares of TH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Theratechnologies' stock price today?

One share of TH stock can currently be purchased for approximately C$1.07.

How much money does Theratechnologies make?

Theratechnologies (TSE:TH) has a market capitalization of C$103.59 million and generates C$80.06 million in revenue each year. The company earns C$-47,240,000.00 in net income (profit) each year or C($0.70) on an earnings per share basis.

How can I contact Theratechnologies?

Theratechnologies' mailing address is 2015 Peel St 5th Floor, MONTREAL, QC H3A 1T8, Canada. The official website for the company is www.theratech.com. The company can be reached via phone at +1-514-3367800.

This page (TSE:TH) was last updated on 3/28/2023 by MarketBeat.com Staff